Genentech's Activase, also known as tissue plasminogen activator, is approved for use only up to three hours after stroke.

FORBES: Brain Repair

For now, treatment of strokes is pretty much limited to Genentech's clot-busting drug, Activase, a tissue plasminogen activator, which is primarily used to treat heart attacks.

FORBES: Repairing The Brain